Standard pre‑examination protocol – must be demonstrated:
Action: Introduce yourself, explain the examination, and obtain verbal consent.
Key observations – “Nephrotic Syndrome / generalized swelling” clues:
Systematic examination – identify aetiology & complications:
Systematic examination – identify aetiology & complications:
Assess:
📋 Case Presentation – (fill in during exam)
This is a _____-year-old _____ child, referred for _____ (generalized swelling / periorbital puffiness / anasarca). On examination, the child appears _____ (well / unwell / in distress), with _____ (pitting edema / ascites / pleural effusion). Weight: _____ percentile, Height: _____ percentile. Blood pressure: _____ (normal / elevated). Cardiovascular: _____ (tachycardia / normal). Respiratory: _____ (shallow / reduced air entry / crackles). Abdomen: _____ (ascites / hepatomegaly / normal). Skin: _____ (striae / bruising / cellulitis / purpura). GPE: _____ (pallor / oedema / normal). Neurological: _____ (alert / confusion / headache).
• Minimal Change Nephrotic Syndrome (MCNS)
• Focal Segmental Glomerulosclerosis (FSGS)
• Membranous Nephropathy
• Membranoproliferative GN (MPGN)
• IgA Nephropathy / HSP Nephritis
• Lupus Nephritis (SLE)
• Post-infectious GN
• Congenital Nephrotic Syndrome
• Secondary: HIV, hepatitis B/C, malaria
• Heart failure, liver disease, protein-losing enteropathy
• Urinalysis: heavy proteinuria (3+ / 4+), microscopic hematuria (20%).
• Spot urine protein/creatinine ratio: >2 (nephrotic range).
• Serum albumin: <2.5 g/dL.
• Serum cholesterol: elevated (>200 mg/dL).
• Serum creatinine & BUN: usually normal (prerenal if volume depleted).
• Complement C3/C4: normal (MCNS), low (MPGN, SLE, post-infectious).
• 24-hour urine protein: >40 mg/m²/hr.
• ANA, anti-dsDNA: lupus nephritis.
• Hepatitis B/C serology, HIV, VDRL.
• C3, C4, CH50: complement levels.
• ASOT, anti-DNase B: post-streptococcal GN.
• Renal biopsy: if steroid-resistant, atypical age (<1 or >12 years), persistent hematuria, low C3.
• Renal ultrasound: exclude CKD, hydronephrosis, renal vein thrombosis.
• Chest X-ray: pleural effusion, cardiomegaly.
• Blood culture: rule out sepsis / peritonitis.
• Tuberculosis screen (TST/IGRA): before immunosuppression.
• Genetic testing: congenital NS, familial FSGS.
• Serum electrolytes: Na, K (hyponatremia, hyperkalemia).
• Coagulation profile: hypercoagulable state (DVT, renal vein thrombosis).
• Lipid profile: hypercholesterolemia.
• Infection screen: peritonitis (ascitic tap if suspected).
• Growth monitoring: weight, height, BMI (steroid effects).
🔹 Management – Across Organ Systems
Salt restriction (<1.5g/day), fluid restriction (if hyponatremia). Diuretics (furosemide) with caution. IV albumin + furosemide in severe anasarca (nephrologist).
Prednisone 60 mg/m²/day (or 2 mg/kg/day) for 4-6 weeks, then alternate-day taper. Steroid-sparing: cyclophosphamide, cyclosporine, mycophenolate, rituximab (steroid-dependent/resistant).
Pneumococcal vaccination (PCV13, PPSV23), influenza annually. Prophylactic penicillin in some centres. Treat infections aggressively (peritonitis, cellulitis, sepsis).
Monitor for DVT, renal vein thrombosis. Anticoagulation if thrombotic event. Treat with heparin, warfarin (nephrologist guidance).
High-quality protein (1.5-2 g/kg/day), calcium/vitamin D supplementation. Monitor growth, manage steroid-induced obesity with diet/exercise.
Family education about home urine dipstick, signs of relapse, complications. Support for steroid side effects, body image, school attendance.
📈 Prognosis
📋 Follow‑up Schedule